Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Jun
23
Today In Oncology
Subgroup Analysis Demonstrates Efficacy of Inavolisib Regimen in Asian Patients With Advanced Breast Cancer
GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD
Chinese Study of HER2-Targeted Combination Therapy for Locally Advanced Breast Cancer
Multi-Cancer Early Detection Test Performs Well in Real-World Asian Cohort
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo